|
RAJ Pharma |
| February 2009 |
|
Editorial – Is the End in Sight for Animal Trials?
The Regulation of Advanced Therapies: Perspectives from the EU
Wolfgang Rehmann and Gareth Morgan compare EU and US regulatory approaches.
Managing Physician-Industry Relationships
Jan Heybroek examines moves by industry and regulators in the US and Europe
to make physician industry relationships more transparent.
Servier v Apotex: A Lesson in Damages
Kathleen Fox Murphy, Simon Cohen and Matthew Royle say a UK judgment offers
guidance on assessing damages for a patent deemed invalid following an injunction.
 |
| |
|
Write For Us |
 RAJ Pharma welcomes articles from regulatory affairs professionals worldwide
|
|
|
| |
|
| |
|
|
|
 Are Humans the Best Model for Human Medicines?
The Safer Medicines Campaign tells Neena Brizmohun that human biology-based tests
can predict the safety of human medicines more accurately than conventional animal
tests.
Brussels ICH Meeting Makes Progress
Dawn Ronan reports on the latest meeting of the International Conference on
Harmonisation steering committee.
Clinical Trial SUSAR Reports in Singapore Dorothy Toh, Chong Limei and Foo Yang Tong explain the new electronic expedited
reporting system for suspected unexpected serious adverse events in clinical
trials.
Plus:
- Guidelines for Human and Veterinary Medicinal Products
- Worldwide Update
- Meetings/Appointments
- Directory of Services
|
| |
|
Take a Trial |
|
RAJ Online
We combined our unrivalled coverage of regulatory affairs with our extensive
e-publishing expertise to bring you RAJ Pharma Online, a product packed with NEW
features that will meet these needs, including: a searchable archive dating back
to 1992, email alerts of the biggest stories, hypertext links to original source
information, secure web-based access and much, much more!
 | |
